Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VLX Ventures is an Israeli life sciences and biotech-focused venture capital firm and tech incubator. It specializes in building and investing in early-stage biopharma therapeutics, computational biology ventures, digital pharma startups, medical devices, and related fields. The firm proactively collaborates with academic researchers to validate concepts before company formation. Its current portfolio spans approximately ten active companies addressing areas such as IVF treatment, cell therapy for various indications including autism and cancer immunotherapies. Portfolio programs are at stages ranging from pre-clinical research through Phase 3 clinical trials[4][5][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VLX Ventures.